Effect of enobosarm, a selective androgen receptor modulator (SARM), on physical function in middle aged and elderly cancer patients, with <5% or ≥5% weight loss

Authors :: Michael L. Hancock
Mary Ann Johnston
Ryan P. Taylor
Mitchell S. Steiner
Source :: Journal of Geriatric Oncology. 3:S98-S99
Publication Year :: 2012
Publisher :: Elsevier BV, 2012.

Subjects :: medicine.medical_specialty
business.industry
Cancer
Physical function
medicine.disease
chemistry.chemical_compound
Endocrinology
Oncology
Selective androgen receptor modulator
chemistry
Weight loss
Internal medicine
medicine
Geriatrics and Gerontology
medicine.symptom
Enobosarm
business

Full Text Access

Tools